PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2013
CASE
AUTH/2614/6/13 Allergan

Allergan market research survey ruled promotional: missing PI, disguised promotion, and pre-/off-licence issues (AUTH/2614/6/13)

Allergan’s UK market research on hypothetical ready-to-use botulinum toxins was ruled promotional and disguised promotion. Breaches included missing prescribing information, pre-licence promotion…

2016
CASE
AUTH/2819/2/16 Otsuka

AUTH/2819/2/16: General Practitioner v Otsuka β€” Jinarc patient materials (No breach)

A GP alleged Jinarc (tolvaptan) patient materials advertised a POM to the public and raised unfounded hopes. The Panel found the materials…

2015
CASE
AUTH/2787/8/15 GlaxoSmithKline

GSK voluntary admission: Incruse + Relvar online ads ran with illegible generic names, missing Relvar PI link and (in some cases) no final certification (AUTH/2787/8/15)

GSK admitted breaches after Incruse+Relvar digital ads appeared with blurred non-proprietary names, broken/incorrect PI links (Relvar PI missing) and some ads published…

2015
CASE
AUTH/2763/5/15 AstraZeneca

AUTH/2763/5/15: PMCPA Director v AstraZeneca (clinical trial disclosure – Caprelsa/Zinforo) – No breach

PMCPA reviewed alleged late disclosure of trials for Caprelsa and Zinforo flagged in an ABPI-funded transparency study. Panel found the older Caprelsa…

2014
CASE
AUTH/2730/9/14 Merck Serono ⭐ Case of the Week

AUTH/2730/9/14: Anonymous health professional v Merck Serono β€” ESHRE congress hospitality and sponsorship (No breach)

Anonymous complaint alleged late-night drinking with HCPs and β€œprescribing-linked” sponsorship at ESHRE 2014. Panel raised concerns about optics and alcohol detail in…

2014
CASE
AUTH/2724/7/14 Ferring Pharmaceuticals

Tillotts v Ferring: Pentasa cost comparison chart ruled misleading for not comparing like with like (AUTH/2724/7/14)

A Pentasa e-detail cost bar chart used a 1.5g/day maintenance dose not quantified in the SPC, unlike comparator products. PMCPA ruled the…

2014
CASE
AUTH/2709/4/14 Actelion

GSK v Actelion: Opsumit promotion and misleading presentation of composite endpoints (AUTH/2709/4/14)

Actelion’s Opsumit detail aid/leavepiece used composite endpoints (morbidity–mortality; death or hospitalisation) without enough context, implying a mortality benefit. Multiple breaches were found;…

2013
CASE
AUTH/2663/11/13 Pierre Fabre

AUTH/2663/11/13: Member of the public v Pierre Fabre β€” Clinical trial disclosure for Javlor (No breach)

A public complaint alleged Pierre Fabre failed to disclose Javlor (vinflunine) trial results. The PMCPA ultimately ruled no breach after appeal, finding…

2016
CASE
AUTH/2846/5/16 Janssen

Janssen voluntary admission: sales manager failed to sit ABPI representatives exam within one year (AUTH/2846/5/16)

Janssen admitted a first-line sales manager did not take the ABPI representatives exam within 12 months of starting the role. The Panel…

2015
CASE
AUTH/2811/12/15 Daiichi-Sankyo UK ⭐ Case of the Week

AUTH/2811/12/15: Anonymous v Daiichi-Sankyo – emailed photo booth images ruled a prohibited gift from a promotional stand

At ESC 2015, Daiichi-Sankyo’s stand included a photo booth that emailed delegates their photos. PMCPA ruled the emailed photos were a gift…

2016
CASE
AUTH/2851/6/16 Novo Nordisk

AUTH/2851/6/16: Anonymous complainant v Novo Nordisk (LinkedIn post about Tresiba) β€” No breach

Complaint alleged Tresiba was promoted to the public via a LinkedIn post generated from a press release. Panel found Novo Nordisk had…

2016
CASE
AUTH/2915/12/16 Janssen

AUTH/2915/12/16 & AUTH/2916/12/16: Anonymous v Janssen-Cilag and Napp (Invokana meeting venue) – No breach

Complaint alleged a world-renowned restaurant venue and buffet would be the main draw for an Invokana promotional meeting. Panel said venue and…

2016
CASE
AUTH/2862/8/16 Takeda

Takeda: exhibition stand sponsorship linked to product advocacy; governance and due diligence failures (AUTH/2862/8/16)

Anonymous complaint about a nurse-led consultancy. Panel found no proven breach for therapy review grants, but ruled breaches where an email linked…

2016
CASE
AUTH/2912/12/16 Astellas Pharma Europe

AUTH/2912/12/16: Astellas Pharma Europe – Betmiga videos posted online by third parties (public promotion via Vimeo)

Astellas admitted Code issues after three Betmiga videos with product claims appeared online via third parties. Panel ruled breaches for two Vimeo…

2017
CASE
AUTH/2936/2/17 Johnson ⭐ Case of the Week

AUTH/2936/2/17: Health professional consultant v Johnson & Johnson – Online Nicorette advertisement (No breach)

Complaint about a Nicorette online ad: use of an infant image and a β€œ43% more effective” claim without absolute data. PMCPA Panel…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training